Boston Completes Enrollment In Pivotal Workhorse Trial
Boston Scientific has completed patient enrollment in the workhorse portion of its PLATINUM clinical program. The trial enrolled 1,532 patients with up to two de novo lesions at
The Liverpool School of Tropical Medicine (LSTM) in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.